Influenza is a serious and global health issue, and it is a major cause of morbidity, fatality, and economic loss every year. Seasonal vaccines exist but are not very effective due to strain mismatches, delays in production, and antigenic drift. This comprehensive overview discusses the current situation of influenza vaccination, including the numerous types of vaccines—inactivated, live attenuated, and recombinant vaccines—and their effectiveness, efficacy, and associated challenges. It highlights the effects of the COVID-19 pandemic on the trends of influenza vaccination and the level to which innovation should be practiced. In the future universal influenza vaccines will be developed that target conserved viral antigens to provide long-term protection to people. In the meantime, novel vaccine delivery platforms, such as mRNA technology, virus-like particle (VLP), and nanoparticle-based systems, and less cumbersome and invasive administration routes, as well as immune responses are also under development to increase access and production capacity. Collectively, these innovations have the potential to not only reduce the global influenza epidemic but also to change the way influenza is prevented and prepare the world for a pandemic.
This book offers a comprehensive exploration of the recent development in the field of colon drug delivery. The classification of colon disorders, epidemiology and burden of colonic disorders are overviewed, also covering formulation approaches targeting colon. The challenges to treat colonic disorders using novel strategies, including pH-sensitive polymers, prodrugs and microbial triggered systems, have been established to ensure that drugs remain safe throughout their transit. It also covered the optimization of dosing regimens. The role of antibiotic therapies along with the advantages and limitations of current approaches are discussed. Futhermore, the authors give detailed Pharmacokinetic and pharmacodynamic aspect. The potential importance of developing effective treatment approaches and the role synthetic and mucoadhesive polymers as biomaterials for colon diseases. The detailed regulatory landscape for colonic drug delivery systems and clinical trials for colonic drug delivery systems is comprehensively discussed.